Tau and p-tau, proteins traditionally associated with neurodegenerative diseases, are also elevated in patients with OSA compared to those without.12 In contrast to vWF, tau concentrations decrease after 1 year of CPAP treatment, and even stabilize tau and other clinical assessments in patients with OSA and subjective cognitive impairment.13 This evidence concerns the gene MAPT and obstructive sleep apnea syndrome.